[ad_1] Ionis Pharmaceuticals IONS, +1.61% and AstraZeneca’s AZN, +0.79% Wainua has been approved by the…
Tag:
Genetic Disorders
-
-
STOCK MARKET
Amgen gets FDA approval for its inflammatory diseases treatment Wezlana
by userby user[ad_1] Amgen AMGN, -2.85% has received approval from the U.S. Food and Drug Administration for…
-
STOCK MARKET
After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology
by userby user[ad_1] After surviving some turbulent market conditions in its first years as a public company,…
-
STOCK MARKET
FDA advisers narrowly back accelerated approval of Sarepta gene therapy
by userby user[ad_1] U.S. Food and Drug Administration advisers voted 8-6 Friday to recommend the agency grant…
-
[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…
-
[ad_1] Drug maker Merck & Co. Inc. announced Sunday a deal to acquire Prometheus Biosciences…
-
[ad_1] Sanofi SA said the U.S. Food and Drug Administration has approved its Altuviiio drug,…